0:000:00
<p><span data-sheets-value= "{"1":2,"2":"<p>This week, we'll discuss phase II results on cabozantinib in patients with advanced bladder cancer. Then, we'll review a study on behaviors related to COVID-19 prevention among cancer survivors. Lastly, we'll hear a discussion about the keynote lecture presented at the First International Summit on Interventional Pharmacoeconomics. </p><p></p><p>Coverage of stories discussed this week on ascopost.com:</p><p><a href=\"https://ascopost.com/news/july-2020/cabozantinib-in-platinum-refractory-metastatic-urothelial-carcinoma/\">Cabozantinib in Platinum-Refractory Metastatic Urothelial Carcinoma</a></p><p><a href=\"https://ascopost.com/news/july-2020/cancer-survivors-are-adhering-to-covid-19-related-preventive-behaviors-but-continuity-of-care-may-be-impacted/\">Cancer Survivors Are Adhering to COVID-19–Related Preventive Behaviors, but Continuity of Care May Be Impacted</a><b><br></b><br></p>"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"...